Clinical Trial Update: Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of a cancer vaccine therapy combined with cyclophosphamide for patients with Stage II-III breast cancer or Stage II-IV ovarian, primary peritoneal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Vaccine therapy

Snippet

Sponsor: Mayo Clinic | Conditions: Recurrent Breast Carcinoma, Recurrent Fallopian Tube Carcinoma | Phase 1 | Status: COMPLETED